Kidney Week

Abstract: FR-PO857

Adverse Maternal-Fetal Outcomes in Pregnant Women with CKD on Hemodialysis: A Single-Center Experience

Session Information

• Women's Health and Kidney Diseases
  November 03, 2023 | Location: Exhibit Hall, Pennsylvania Convention Center
  Abstract Time: 10:00 AM - 12:00 PM

Category: Women's Health and Kidney Diseases

• 2200 Women's Health and Kidney Diseases

Authors

• Andrade-Sierra, Jorge, Universidad de Guadalajara Centro Universitario de Ciencias de la Salud, Guadalajara, Jalisco, Mexico

Jorge Andrade-Sierra,

• Bautista Melo, Berenice, Instituto Mexicano del Seguro Social Delegacion Jalisco, Guadalajara, Jalisco, Mexico

Berenice Bautista Melo,

• Carvallo Venegas, Mauricio, Instituto Mexicano del Seguro Social Delegacion Jalisco, Guadalajara, Jalisco, Mexico

Mauricio Carvallo Venegas,

• Banda Lopez, Adriana, Instituto Mexicano del Seguro Social Delegacion Jalisco, Guadalajara, Jalisco, Mexico

Adriana Banda Lopez,

• Mendoza Cabrera, Salvador, Instituto Mexicano del Seguro Social Delegacion Jalisco, Guadalajara, Jalisco, Mexico

Salvador Mendoza Cabrera,

• Parra Guerra, Ricardo, Instituto Mexicano del Seguro Social Delegacion Jalisco, Guadalajara, Jalisco, Mexico

Ricardo Parra Guerra,

• Moreno De los Rios, María del Rosario, Instituto Mexicano del Seguro Social Delegacion Jalisco, Guadalajara, Jalisco, Mexico

María del Rosario Moreno De los Rios,

• Cerrillos, Jose Ignacio, Instituto Mexicano del Seguro Social Delegacion Jalisco, Guadalajara, Jalisco, Mexico

Jose Ignacio Cerrillos,

• Evangelista-Carrillo, Luis Alberto, Instituto Mexicano del Seguro Social Delegacion Jalisco, Guadalajara, Jalisco, Mexico

Luis Alberto Evangelista-Carrillo,

• Medina Perez, Miguel, Instituto Mexicano del Seguro Social Delegacion Jalisco, Guadalajara, Jalisco, Mexico

Miguel Medina Perez,

Background

Chronic kidney disease (CKD) pregnant women are at high risk of adverse maternal and fetal outcomes (AMAFO). 4% of women of childbearing age suffer from CKD, an independent risk factor for prematurity, low birth weight, neonatal death, and preeclampsia. Objective: To determine the incidence of AMAFO in pregnant women with CKD in hemodialysis (HD).

Methods

Observational retrospective study of 30 patients with CKD in HD and pregnancy from Aug 2017 to Dec 2021. Sociodemographic data, comorbidities, and AMAFO were recorded and analyzed.

Results

The incidence of adverse maternal events was 33%, the most frequent was preeclampsia with severe features (17%), followed by preeclampsia (7 %), HELLP syndrome (3%), gestational diabetes (3%), and placental abruption (3%). Neither patient died during the follow-up. 90% of the newborns present with adverse fetal outcomes, 90% with low birth weight, 40% with prematurity, 13 % with transient tachypnea of the newborn, 7% with premature rupture of the membranes, 7% with fetal distress, and 17% died.

Conclusion

There was a 33% incidence of adverse maternal events and 90% of adverse fetal outcomes in pregnant women with CKD in HD, with only 10% of pregnancies without AMAFO.